Tiffany, Kors to Re...
Health Care: Health Services
NxStage Medical Inc. (NXTM: NASDAQ)
$13.87 0.27 | 1.99%
05/24/13 - 04:00 PM ET
288.64K / 308.50K
Vol / Avg. Vol:13.52 / 13.60
Open / Prev. Close:13.52 - 13.95
Today's Range:10.15 - 17.15
52 Wk Range:20.89%
Performance YTD:TheStreet Rating:
Portfolios with NXTM
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- UserPART 6 JPMorgan 28th Annual...
- Userearly retire
- UserPART 6 JPMorgan 27th Annual...
- UserMUTE
- UserPART 1 JPMorgan 26th Annual...
- UserMaking Money Portfolio
- UserIndagator "Homerun&quo...
Latest NXTM Headlines from TheStreet
- NxStage Medical Incorporated Stock Upgraded (NXTM) 08.10.12 | 05:08 am
- NxStage Medical Stock Hits New 52-Week Low (NXTM) 05.11.12 | 10:05 am
- 7 Stocks Rising on Huge Volume 02.09.12 | 03:02 pm
- NxStage Medical Stock Hits New 52-Week Low (NXTM) 01.12.12 | 10:01 am
- NxStage Medical Stock Falls On Unusually High Volume (NXTM) 11.03.11 | 03:11 pm
- Insiders Trading KIOR, NWN, GTXI 06.29.11 | 10:06 am
- NxStage Medical Stock Falls On Unusually High Volume (NXTM) 05.04.11 | 02:05 pm
- NxStage Medical Stock Falls On Unusually High Volume (NXTM) 02.22.11 | 03:02 pm
- Nxstage Medical CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.05.10 | 12:11 pm
- Insiders Trading GE, AAPL, INTC and GOOG 10.20.10 | 09:10 am
Press Releases for NXTM
- NxStage Announces New Agreements With DaVita - PR Newswire 05.21.13 | 05:05 pm
- NxStage Announces Second Quarter 2013 Investor Conference Schedule - PR Newswire 05.09.13 | 08:05 am
- NxStage Announces FDA Clearance For New High Flow Capabilities With NxStage System One - PR Newswire 04.30.13 | 08:04 am
- NxStage Names Robert G. Funari Chairman Of The Board - PR Newswire 04.25.13 | 04:04 pm
- NxStage® To Report First Quarter Fiscal 2013 Financial Results - PR Newswire 04.09.13 | 08:04 am
- NxStage Completes Move To Direct Sales In UK - PR Newswire 04.08.13 | 08:04 am
- Home Hemodialysis Patients Urge Medicare To Fix HHD Training Reimbursement - PR Newswire 03.20.13 | 08:03 am
- NxStage Educational Reception At Annual Dialysis Conference Features Celebrity And Former NxStage User Stephen Furst - PR Newswire 03.08.13 | 12:03 pm
- NxStage Announces CE Mark Approval, First Clinical Use Of Its Single Needle For Dialysis Patients - PR Newswire 02.25.13 | 08:02 am
- NxStage Announces CE Mark Approval For New High Flow Capabilities With System One - PR Newswire 02.21.13 | 08:02 am
Partner Headlines for NXTM
- 2 Biotech Companies With Positive Results That May Be Headed In Opposite Directions - Seeking Alpha 11.08.12 | 09:11 am
- FormFactor CHATTER and Five Fresh Investor Insights from Wall Street - Wall St. Cheat Sheet 07.03.12 | 01:07 pm
- Analyst INSIGHTS: Teva Pharmaceutical and 4 Stocks with New Analysis - Wall St. Cheat Sheet 06.18.12 | 12:06 pm
- 16 Healthcare Stocks Deeply Discounted From Target Price - Seeking Alpha 01.12.12 | 09:01 am
- Rodman & Renshaw Maintains NxStage Medical Market Perform - Benzinga 11.03.11 | 04:11 pm
- Contrarian Ideas: 25 High Growth Stocks With Significant Short Selling - Seeking Alpha 06.06.11 | 08:06 am
- Insider Buys and Sells: Monsanto, Google - Seeking Alpha 10.25.10 | 08:10 am
- NxStage Medical Chairman Sells 500,000 Shares of NXTM - Benzinga 08.13.10 | 05:08 pm
- UPDATE 1-NxStage Q2 loss narrows, ups 2010 revenue view - Reuters 07.23.10 | 08:07 am
- UPDATE 1-NxStage posts narrower-than-expected quarterly loss - Reuters 05.05.10 | 08:05 am
